Status
Conditions
Treatments
About
This multi-center study is to focus on patients with sepsis in Intensive Care Units (ICUs) in order to better understand the complex host-pathogen interaction and clinical heterogeneity associated with sepsis. Understanding this heterogeneity may allow the development of novel diagnostic approaches. Data from patients will be analyzed using state-of-the art analytical algorithms for biomarker discovery including machine learning and multidimensional mathematical modelling to explore the large datasets generated. In order to discover digital biomarkers for the study endpoints a case-control study design will be used to compare data patterns from patients with sepsis (cases) and those without sepsis (controls).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion Criteria (cases)
Inclusion Criteria (controls)
Exclusion criteria
17,500 participants in 2 patient groups
Loading...
Central trial contact
Adrian Egli, PD Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal